Denotivir

• CAT Number: I025887
• CAS Number: 51287-57-1
• Molecular Formula: C18H14ClN3O2S
• Molecular Weight: 371.84
• Purity: 98%
• Synonyms: Denotivir; T15; T 15; T-15
• Solubility: To be determined
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: 5-benzamido-N-(4-chlorophenyl)-3-methyl-1,2-thiazole-4-carboxamide
• InChI: InChI=1S/C18H14ClN3O2S/c1-11-15(17(24)20-14-9-7-13(19)8-10-14)18(25-22-11)21-16(23)12-5-3-2-4-6-12/h2-10H,1H3,(H,20,24)(H,21,23)
• InChIKey: ZPBLNADJHWHOEP-UHFFFAOYSA-N
• SMILES: CC1=NSC(=C1C(=O)NC2=CC=C(C=C2)Cl)NC(=O)C3=CC=CC=C3

Denotivir（Cat No.:I025887）is a novel antiviral medication under investigation for the treatment of chronic viral infections, particularly hepatitis B and HIV. It works by inhibiting viral replication, specifically targeting viral enzymes such as reverse transcriptase, which are essential for the virus to reproduce and spread in the body. Early clinical trials have shown promising results, with Denotivir potentially offering a new treatment option with fewer side effects compared to current antiviral therapies. However, it remains in the experimental phase, and further studies are needed to confirm its safety and efficacy.